Latest news with #Lapidus
Yahoo
29-07-2025
- Business
- Yahoo
Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions
Early VIRTUGUIDE™ surgeons report a 30-minute reduction in surgical time versus traditional treatment1,2,*,** WEST CHESTER, Penn., July 29, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) – Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, today announced the launch of the VIRTUGUIDE™ System. This AI-powered, patient-matched solution is designed to support Lapidus procedures2, a type of bunion surgery that helps realign the foot by joining two bones near the arch (the first metatarsal bone and the medial cuneiform).3 The system uses pre-operative planning software, developed in collaboration with PeekMed®, to assess each patient's bunion and make personalized recommendations for the intended correction.2 Bunions are among the most common foot problems, affecting nearly one-third of adults in the U.S.4, yet traditional Lapidus surgery to treat the condition is often challenging.5,6 The VIRTUGUIDE™ AI Lapidus System addresses this by enabling a streamlined approach and reducing surgical complexity.2** Early users estimated procedural time savings of at least 30 minutes when using the system compared to their previous technique.1,* "VIRTUGUIDE™ has completely transformed my approach to bunion surgery, making a complex Lapidus procedure significantly easier and faster. Since adopting VIRTUGUIDE™, my surgical corrections have been spot-on—what I plan preoperatively is exactly what I achieve in the operating room," said Michael Campbell, M.D., FAAOS, a board-certified orthopaedic surgeon at Atlantic Orthopaedic Specialists.± "This improved accuracy leads to better outcomes, and the ability to present the pre-operative plan to my patients helps address their questions and ease their concerns§." "The VIRTUGUIDE™ System is a pivotal advancement in AI-powered surgical precision for treating bunion deformities—a common, painful, and potentially debilitating condition affecting nearly one-third of Americans4," said Oray Boston, Worldwide President of Trauma, Extremities, Craniomaxillofacial, Animal Health and Sports Medicine, Orthopaedics, Johnson & Johnson MedTech. "This milestone marks an important step forward, as VIRTUGUIDE™ becomes the latest addition to our growing portfolio of VELYS™ Enabling Tech solutions. By automating surgical planning and tailoring instrumentation to each patient, the system helps reduce complexity in the operating room and helps surgeons to achieve the intended correction2,7**." This launch follows the 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the Pre-operative Planning Software, granted earlier this year.‖ The system is now available in the U.S. For more information, visit Orthopaedic Solutions from Johnson & Johnson MedTech Across Johnson & Johnson, we are tackling the world's most complex and pervasive health challenges. In Orthopaedics, we are on a mission to keep people moving by leveraging our deep expertise in joint reconstruction, robotics and enabling tech, spine, sports, trauma, and extremities, to develop the next generation of medtech solutions. We offer one of the most comprehensive Orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. For more, visit our website or follow us on LinkedIn. About Johnson & JohnsonAt Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity. Learn more about our MedTech sector's global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at Follow us at @JNJMedTech and on LinkedIn. DePuy Synthes Products, Inc. is a Johnson & Johnson company. Cautions Concerning Forward-Looking StatementsThis press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding the VIRTUGUIDE™ System. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: uncertainty of commercial success; challenges to patents; competition, including technological advances, new products and patents attained by competitors; manufacturing difficulties and delays; product efficacy or safety concerns resulting in product recalls or regulatory action; changes to applicable laws and regulations, including global health care reforms; changes in behavior and spending patterns of purchasers of health care products and services; and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's most recent Annual Report on Form 10-K, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and in Johnson & Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments. Important Information: Prior to use, refer to the instructions for use supplied with the device(s) or indications, contraindications, warnings and precautions. © Johnson & Johnson and its affiliates 2025. All rights reserved. US_ORT_FTAK_398543 * Statements are based on responses from 10 surgeons, having completed a total of 150 Lapidus procedures using the VIRTUGUIDE™ System. The statements reflect surgeon experience, not clinical outcomes, and were included if at least 6 surgeons agreed.** VIRTUGUIDE™ System compared to Treace Medical Lapiplasty® 3-Plane System and Paragon28 Bun-Yo-Matic Lapidus Clamp System.± Dr. Michael Campbell, M.D., FAAOS is a paid consultant for Johnson & Johnson MedTech.§These statements reflect the experience, approach and opinion of the surgeon.‖ The VIRTUGUIDE™ Planning Software, powered by PeekMed®, is developed and owned by Peek Health, S.A. Refer to for user manuals, FAQ's, or any support. The third-party trademarks used herein are trademarks of their respective owners. 1 Johnson & Johnson MedTech, VIRTUGUIDE™ System Early Surgeon Experience Report December 2024, Windchill Document# EM24-00282 Johnson & Johnson and its affiliates VIRTUGUIDE™ System Feature Memo. 9th Dec 2024. Windchill # EM24-0027. 3 American Orthopaedic Foot & Ankle Society. Lapidus Procedure. FootCareMD. Accessed June 24, 2025. 4 MedlinePlus. Bunion: Genetic and Environmental Causes. U.S. National Library of Medicine. Available at Accessed March 2025.5 Rupke T. The modified Lapidus procedure for the treatment of moderate to severe hallux valgus. Orthogate. Published October 30, 2013. Accessed June 26, 2025. Foran IM, Lin J, Hamid KS, Lee S. Technical tip: kerfing for Lapidus arthrodesis: deformity correction with minimal bone resection. J Foot Ankle Surg. 2021;60(2):424-427. doi:10.1053/ 7 Sobrón FB, Santos-Vaquinhas AD, Alonso B, et al. Technique tip: 3D printing surgical guide for pes cavus midfoot osteotomy. J Foot and Ankle Surgery. 2022;28:371-377. Media Contacts:Erin Farley efarley1@ Abhi Basuabasu26@ Investor Contact:investor-relations@ View original content to download multimedia: SOURCE Johnson & Johnson MedTech Sign in to access your portfolio
Forbes
21-03-2025
- Business
- Forbes
The New Printemps Store In New York Is Fun
The shopping floor at the new Printemps store I was prepared not to like the new Printemps store in New York before I saw it. After all, how did these French retailers think they could just drop into New York, in the financial district no less, and turn sophisticated and jaded New Yorkers' heads? The U.S. is a tempting market, it's the largest consumer market in the world but it's also the graveyard of European brands and retailers who've come here to make their business grow. Shoes at the new Printemps store But after seeing the effort, attention, thought and creativity put into every inch of the store, it's hard not to like it. If you're a tourist in New York or you just like to shop, you'd miss out by not heading down to One Wall Street where the store recently opened. I've toured a lot of stores and I thought I'd be in the 54 thousand square foot shop for 15 minutes but I was there for over an hour. There's a lot to see. There are many discreet areas and each one has been thoughtfully decorated. There's a ton of vintage product that's unique and interesting (and expensive) but fun to see. And like their Paris store but on a smaller scale, the food offerings will keep you inside. There's a lot of interesting vintage product at the new Printemps store. It's fun and interesting and that's what shopping should be. It's worth seeing even if you weren't planning to be in FiDi. But if you're a tourist, there's now lots of things that will bring you nearby and sparing another hour to see the Printemps store is a good use of your time. More vintage at the new Printemps store Arianne Lapidus of Printemps said that since Barney's closed there's a gap in the market that Printemps is attemping to fill. While the new store will not remind you of Barney's, that's probably a good thing. I saw the financials of many of the small brands that were sold in Barney's and they were almost all unprofitable; what was a win for Barney's wasn't necessarily a good financial outcome for its vendors. And time has passed, we don't need to recreate Barney's, we need to see what comes next and Printemps is trying to be that new thing. For now, the crowds are literally lining up at the door. The crowd waiting to get in. All the entrances have lines, this one is at One Wall Street But about eventual success, there's no way to know right now. Here's what I wonder about: - Will the people who live, work and visit FiDi keep coming in or will it be one and done? - Will Printemps keep the products as fresh and interesting as they were at the store opening? Lapidus of Printemps made the point that Printemps owns all the inventory, there are no leased departments. What she was getting at is that they didn't let anything but good merchandising drive their product decisions and that's what retail should be. The beauty corridor in the Printemps store - Will they keep the layout? There's a champagne bar, a cocktail bar, a raw bar and a cafe. There's also a corridor on the upper level (pictured above) that you have to walk through to get from one end of the store to the other. Lapidus of Printemps says that half the bramds sold in the beauty area are not otherwise available in the U.S. The floor in the new Printemps store was copied from Versailles. Over time, the economics of retail can be demanding and pressure-filled. When vendors come along who will give you discounts and deals if you feature them prominently, it's tempting to boost the bottom line whether those are the right merchandising decisions or not. Whether Printemps succumbs to that, there's no way to know. It's a critical issue. Printemps is planning continued designer collaborations, events, integrated food and beverage and beauty services. If consumers think that a fun afternoon is spent wandering and eating at the Printemps store, then it's going to be a huge success. But if the cost and effort of having interesting and unique vintage becomes uneconomic, if the tourists or residents who spend aren't coming back, if the food is lackluster, if having sales begins to drive what's on offer, if making deals with big brands becomes important to the business, then the store can go on for a while but in the long run it won't make it. Lapidus says 'we're all looking for a little beauty and wonder' and this new store is where 'New York and Paris meet.' If Printemps can keep that approach and make it work, then perhaps a great French retailer can really make it in New York and the U.S.
Yahoo
29-01-2025
- Entertainment
- Yahoo
Prime Video Sets Premiere Date for ‘Paradis City' From ‘Snabba Cash' Scribe Jens Lapidus: ‘More Hell Than Paradise' (EXCLUSIVE)
Prime Video has set the global launch date for its premium Swedish show 'Paradis City,' a fast-paced dystopian actioner, based on 'Snabba Cash' scribe Jens Lapidus' eponymous stand-alone novel. The six-part series, due to launch March 7 exclusively on Prime Video, is being showcased as a works in progress today Jan. 29 at Göteborg's TV Drama Vision. More from Variety 'House of David' Trailer: Biblical Story Springs to Life in Amazon Series Amazon Orders Suburban Scandal Docuseries About a 15-Year-Old Suing His Public School for Spying 'Invincible' Season 3 Adds Nine to Cast, Including Jonathan Banks, Aaron Paul, Simu Liu, Tzi Ma Produced by Lapidus' shingle Strive Studios, the show is to-lined by Alexander Abdallah ('Snabba Cash'), Julia Ragnasson ('Midsommar,' 'Blinded') and Sverrir Gudnason ('Falling,' 'Face to Face'). Fenar Ahmad ('Darkland') and Alain Darborg ('Red Dot') serve as directors. Adapted for the small screen by head writer Björn Paqualin ('Occupied,' 'Thicker than Water') with Michaela Hamilton ('A Class Apart') and Oliver Dixon ('The Lawyer'), 'Paradis City' is set in the near future. The polarization of Swedish society has reached unprecedented levels and prison-like walls are separating privileged citizens from vulnerable and supposedly dangerous zones, governed by special laws. When the Home Secretary is abducted by masked men at a rally in one of the largest 'no-go' zones, Paradis City, special agents Fredrika (Ragnarsson) enlists Emir (Abdallah), an ex-MMA fighter facing life in prison to find the politician, otherwise he might risk losing a chance to see his daughter again. 'It's more Hell City than Paradise City,' says Lapidus about his dystopian universe where only viewers can decide who are the good or bad guys on each side of the walls. 'The titles of my novels have different interpretations, but this is obviously ironic,' continues the high-profile Swedish novelist and former criminal defence lawyer, whose 'Snabba Cash' Stockholm noir trilogy turned into global hits in libraries and on small and silver screens. The Netflix reboot, co-created by Lapidus, also put Abdallah's name on the list of talent to watch. But what made the best-selling crime writer break away from his distinctively realistic vision of Stockholm's underworld to tap into sci-fi? 'Well I had moved to Mallorca, Spain in 2017, and quit my job as a lawyer to fully focus on writing,' Lapidus tells Variety. 'Listening to and reading the news about Sweden from afar, I started to see a country wrecked by gang violence. That's when I got the idea to draw a Sweden seen from a distance, not geographical but in time. I started thinking-what would happen if this violence and criminality were getting out of control? What would be the nightmare scenario? Well that nightmare scenario would be a society unable to protect itself and suddenly forced to build gigantic walls to fence off the 'dangerous' people.' For Lapidus, his dystopian vision of Sweden is not that far from reality. 'Stockholm is among the most segregated cities in Europe, therefore the walls in 'Paradis City' are an extrapolation, a metaphorical depiction of what already exists,' he to the TV show that he executive produced, Lapidus says the key questions it asks and he hopes the audience will reflect upon, are 'how do western democracies deal with polarization in society? Does the end justify the means?' Producer Niklas Wikström Nicasto, a partner in Strive Studios, says the show 'is structured almost like a feature, with a fast pace. It literally follows the novel, although of course, story-wise we've made changes.'With the 1981 John Carpenter movie 'Escape from New York' starring Kurt Russell as one of the points of reference, the creatives made sure the tone, style and characterisation would be broadened. Comparing the characters in the series to Frodo in 'The Lord of the Rings' who comes across the Dwarves and Elves in Middle-earth, the author says his protagonists also go on a journey. 'In the show, you cross different groups, different worlds. This gives you a broader understanding of society,' Lapidus notes. Casting-wise, enrolling Alexander Abdallah to play the charismatic and fierceful Emir was an obvious choice, but finding the right actress to play special agent Fredrika was a long and winding process. 'Julia got the part only three weeks before shooting. It was crazy. But we're so happy with our choice. Both Alexander and Julia are among the most talented of their generation,' says Nicastro. Originally ordered by Viaplay, the series ended up with Prime Video when the Nordic streamer hit financial trouble and decided to sell off rights to bring in extra cash . 'Amazon Prime came in during production. They've been super enthusiastic from day one, and our collaboration went very smoothly,' said the producer who is hoping for the brand to carry on. 'The novel is a closed story, but our show has strong returnable potential,' he claims. Commenting on 'Paradis City,' Karin Lindström, head of originals at Nordic Amazon MGM Studios/Prime Video, said: 'We are always on the lookout for established, impactful IP with strong local relevance for our scripted titles. Jens Lapidus' book immediately stood out to us, not only because of its compelling narrative but also due to his close collaboration with the production team and alignment with the producers' vision for engaging the audience with this story.' 'Paradis City' was part of a package of nine scripted originals acquired from Viaplay in February 2024 by the U.S. global streamer, as part of its commitment to the Nordic region, which remains as strong as ever as Lindström told Variety: 'We aim to offer a diverse mix of local scripted and unscripted titles that not only drive new Prime subscriptions but also encourage members to return regularly, creating a true one stop entertainment destination. Our strategy has proven successful in blending international and local content to achieve this goal,' she said. 'While the exact number of titles varies depending on their potential impact, for 2025 we plan to launch six scripted and 14 unscripted titles across Sweden, Norway, and Denmark. Looking ahead, we have no intention of scaling back and remain committed to delivering a strong and engaging lineup.' Best of Variety What's Coming to Netflix in February 2025 New Movies Out Now in Theaters: What to See This Week What's Coming to Disney+ in February 2025
